Abstract
Hypertensive disorders of pregnancy complicate 7% to 10% of pregnancies and are among the major causes of maternal and perinatal morbidity and mortality. Recently American College of Obstetricians and Gynecologists Taskforce on Hypertension during Pregnancy modified the diagnosis and management of hypertension in pregnancy, recommending prompt diagnosis, admission, close monitoring, and treatment. They strive to decrease maternal mortality and systemic complications. Labetalol, hydralazine, or nifedipine are considered first-line treatment, and either can be used to stabilize the patient with similar outcomes. Definite treatment is delivery of the fetus and should be considered based on the etiology of the hypertensive crisis and gestational age.
TY - JOUR
T1 - Hypertensive emergencies in pregnancy.
AU - Vadhera,Rakesh B,
AU - Simon,Michelle,
PY - 2014/10/15/entrez
PY - 2014/10/15/pubmed
PY - 2015/7/15/medline
SP - 797
EP - 805
JF - Clinical obstetrics and gynecology
JO - Clin Obstet Gynecol
VL - 57
IS - 4
N2 - Hypertensive disorders of pregnancy complicate 7% to 10% of pregnancies and are among the major causes of maternal and perinatal morbidity and mortality. Recently American College of Obstetricians and Gynecologists Taskforce on Hypertension during Pregnancy modified the diagnosis and management of hypertension in pregnancy, recommending prompt diagnosis, admission, close monitoring, and treatment. They strive to decrease maternal mortality and systemic complications. Labetalol, hydralazine, or nifedipine are considered first-line treatment, and either can be used to stabilize the patient with similar outcomes. Definite treatment is delivery of the fetus and should be considered based on the etiology of the hypertensive crisis and gestational age.
SN - 1532-5520
UR - https://www.unboundmedicine.com/medline/citation/25314092/Hypertensive_emergencies_in_pregnancy_
DB - PRIME
DP - Unbound Medicine
ER -
